Steven Frank Receives Stock Award at Biocryst Pharmaceuticals Inc (BCRX) — SEC Form 4, Sep 02, 2026

SEC Form 4 · No Market Transaction
Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner
Director
TXN 2026-08-31 · FILED 2026-09-02
Equity Position 36.7K sh 35,459 → 36,747
Equity Change +3.6% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-09-02
Report Date
2026-09-02
Accession No.
0000882796-26-000057
Accepted At
2026-09-02 20:04 UTC
Reporting Owner
Name Relationship
Steven Frank CIK 0001583886
Director
Steven Frank at Biocryst Pharmaceuticals Inc Full insider history
Bought (12 mo) —
Sold (12 mo) —
More from this insider at Biocryst Pharmaceuticals Inc
All filings by this insider at Biocryst Pharmaceuticals Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2026-08-31 A - Award/Grant 1,288 A $9.70 +$12,494 36,747 Direct
Footnotes (1)
F1
Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $12,500. Show more
5%+ Holders · 13D/G 4 filers
Other insiders at Biocryst Pharmaceuticals Inc
All Biocryst Pharmaceuticals Inc insider activity
GET /v1/forms/4/0000882796-26-000057 API docs
View Original SEC Filing